three of the most potent inhibitors found in this study , mercaptosuccinate , penicillamine , and alpha-mercaptopropionylglycine , are currently used as slow-acting drugs in the treatment of rheumatoid arthritis .
C0030817
penicillamine
C0003873
rheumatoid arthritis